Oklo (OKLO) is trading higher as markets continue to react to a cluster of recent federal approvals that investors view as meaningful de-risking steps for the company’s Aurora Powerhouse reactor program and its isotope ambitions. The latest regulatory headlines, released March 17, 2026, included two Department of Energy Nuclear Safety Design Agreement (NSDA) approvals and an NRC-issued materials license tied to Oklo’s wholly owned isotope subsidiary, Atomic Alchemy.

For an early-stage advanced nuclear developer, incremental licensing and permitting progress tends to drive outsized stock moves because it can shift timelines, financing assumptions, and customer confidence. The DOE NSDA approvals are seen as reinforcing the pathway for Oklo’s DOE-linked deployment work at Idaho National Laboratory, while the NRC materials license provides a concrete regulatory footing for isotope handling, processing, and distribution activities—supporting the company’s broader “energy + isotopes” strategy.

Traders are likely to stay focused on follow-on regulatory milestones for Aurora and any additional government or commercial counterparties that validate demand, particularly around data centers and large power users. With the sector sensitive to policy and permitting signals, any further NRC review progress, DOE program updates, or new customer announcements could quickly become the next catalyst for OKLO.